a08 SGACLC 1.
Methods | RCT ‐ 1982‐85 | |
Participants | 306 patients | |
Interventions | surgery vs surgery + chemotherapy mitomycin C 0.08‡ cyclophosphamide 2‡ tegafur* 12‡ | |
Outcomes | survival | |
Notes | mitomycin C given in 10 cycles tegafur daily treatment > 6 months | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Low risk | A ‐ Adequate |